Reportlinker Adds Urological Disorders Therapeutics to 2016 – Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Ma…

NEW YORK, Aug. 31 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:

Urological Disorders Therapeutics to 2016 – Increasing Awareness
and Aging Population will Drive the Benign Prostatic Hyperplasia
and Urinary Incontinence Markets

http://www.reportlinker.com/p0286296/Urological-Disorders-Therapeutics-to-2016—Increasing-Awareness-and-Aging-Population-will-Drive-the-Benign-Prostatic-Hyperplasia-and-Urinary-Incontinence-Markets.html

Urological Disorders Therapeutics to 2016 – Increasing Awareness
and Aging Population will Drive the Benign Prostatic Hyperplasia
and Urinary Incontinence Markets

Summary

GBI Research’s Therapeutic Analysis report, “Urological
Disorders Therapeutics to 2016 – Increasing Awareness and Aging
Population will Drive the Benign Prostatic Hyperplasia and Urinary
Incontinence Markets”, provides in-depth analysis of unmet needs,
drivers and barriers that impact the global urological disorders
market. This pharmaceutical and healthcare report analyzes the
markets for urological disorders in the US, the top five countries
in Europe (the UK, Germany, France, Italy and Spain) and Japan.
Treatment usage patterns, sales, prices and volumes are forecast
until 2016 for the key geographies as well as the leading
therapeutic segments. Further, the report provides competitive
benchmarking for the leading companies and analyzes the mergers,
acquisitions and lic

‘/>”/>

SOURCE